Mesylate Apatinib for Stage Ⅳ STS After Failure of Chemotherapy
Clinical trial NCT03121846 · UNKNOWN
Trial details
- NCT number
- NCT03121846
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-01
- Primary completion
- 2018-11-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.